|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Sales | |||||
| Cost of Sales | |||||
| Gross Profit | |||||
| Research and Product Development | |||||
| Selling and Marketing | |||||
| General and Administrative | |||||
| Operating (Loss) Income | |||||
| Other Income (Expense): | |||||
| Realized Gain on Available-for-Sale Investments | |||||
| Interest Expense | |||||
| Interest Income | |||||
| Total Other Expense, net | |||||
| Net Loss | |||||
| Net Loss Per Share Attributable to Common Stockholders - Basic (in dollars per share) | |||||
| Net Loss Per Share Attributable to Common Stockholders - Diluted (in dollars per share) | |||||
| Weighted Average Number of Shares of Common Stock Outstanding - Basic (in shares) | |||||
| Weighted Average Number of Shares of Common Stock Outstanding - Diluted (in shares) | |||||
Loading...